• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Predictive value of CT imaging findings in COVID-19 pneumonia at the time of first-screen regarding the need for hospitalization or intensive care unit.首次筛查时CT影像表现对新型冠状病毒肺炎患者住院或入住重症监护病房需求的预测价值
Diagn Interv Radiol. 2021 Sep;27(5):599-606. doi: 10.5152/dir.2020.20421.
2
[Spatial and temporal distribution and predictive value of chest CT scoring in patients with COVID-19].新型冠状病毒肺炎患者胸部CT评分的时空分布及预测价值
Zhonghua Jie He He Hu Xi Za Zhi. 2021 Mar 12;44(3):230-236. doi: 10.3760/cma.j.cn112147-20200522-00626.
3
CT imaging features of COVID-19 pneumonia: initial experience from Turkey.土耳其的 COVID-19 肺炎 CT 影像学特征:初步经验。
Diagn Interv Radiol. 2020 Jul;26(4):308-314. doi: 10.5152/dir.2020.20307.
4
Temporal relationship between serial RT-PCR results and serial chest CT imaging, and serial CT changes in coronavirus 2019 (COVID-19) pneumonia: a descriptive study of 155 cases in China.新型冠状病毒(COVID-19)肺炎的实时逆转录聚合酶链反应(RT-PCR)结果与系列胸部 CT 影像学及系列 CT 改变的时间关系:中国 155 例的描述性研究。
Eur Radiol. 2021 Mar;31(3):1175-1184. doi: 10.1007/s00330-020-07268-9. Epub 2020 Sep 15.
5
CT Features of COVID-19 Pneumonia Differ Depending on the Severity and Duration of Disease.新冠肺炎肺炎的 CT 特征取决于疾病的严重程度和持续时间。
Rofo. 2021 Jun;193(6):672-682. doi: 10.1055/a-1293-9163. Epub 2020 Dec 17.
6
Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19).新冠肺炎(COVID-19)康复过程中胸部 CT 肺部变化的时间进程。
Radiology. 2020 Jun;295(3):715-721. doi: 10.1148/radiol.2020200370. Epub 2020 Feb 13.
7
Analysis of clinical features and imaging signs of COVID-19 with the assistance of artificial intelligence.人工智能辅助分析 COVID-19 的临床特征和影像征象。
Eur Rev Med Pharmacol Sci. 2020 Aug;24(15):8210-8218. doi: 10.26355/eurrev_202008_22510.
8
A new imaging sign in COVID-19 pneumonia: vascular changes and their correlation with clinical severity of the disease.新型冠状病毒肺炎的一种新影像学征象:血管改变及其与疾病严重程度的相关性。
Diagn Interv Radiol. 2021 Mar;27(2):172-180. doi: 10.5152/dir.2020.20346.
9
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.新型冠状病毒 2019 年 SARS-CoV-2 患者的影像学和临床特征。
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1275-1280. doi: 10.1007/s00259-020-04735-9. Epub 2020 Feb 28.
10
CT findings of COVID-19 in follow-up: comparison between progression and recovery.新冠肺炎 CT 随访表现:进展与恢复的比较。
Diagn Interv Radiol. 2020 Jul;26(4):301-307. doi: 10.5152/dir.2019.20176.

引用本文的文献

1
Predicting Severe Respiratory Failure in Patients with COVID-19: A Machine Learning Approach.预测新型冠状病毒肺炎患者的严重呼吸衰竭:一种机器学习方法。
J Clin Med. 2024 Dec 4;13(23):7386. doi: 10.3390/jcm13237386.
2
Time-dependent CT score-based model for identifying severe/critical COVID-19 at a fever clinic after the emergence of Omicron variant.基于时间依赖性CT评分的模型,用于在奥密克戎变异株出现后在发热门诊识别重症/危重症新冠肺炎
Heliyon. 2024 Mar 25;10(7):e27963. doi: 10.1016/j.heliyon.2024.e27963. eCollection 2024 Apr 15.
3
Quantitative Computed Tomography Lung COVID Scores with Laboratory Markers: Utilization to Predict Rapid Progression and Monitor Longitudinal Changes in Patients with Coronavirus 2019 (COVID-19) Pneumonia.定量计算机断层扫描肺COVID评分与实验室指标:用于预测2019冠状病毒病(COVID-19)肺炎患者的快速进展并监测其纵向变化
Biomedicines. 2024 Jan 6;12(1):120. doi: 10.3390/biomedicines12010120.
4
Detection of COVID-19 and its pulmonary stage using Bayesian hyperparameter optimization and deep feature selection methods.使用贝叶斯超参数优化和深度特征选择方法检测新型冠状病毒肺炎及其肺部阶段
Expert Syst. 2022 Sep 26:e13141. doi: 10.1111/exsy.13141.
5
Effectiveness of Tocilizumab in Patients with Severe or Critical Lung Involvement in COVID-19: A Retrospective Study.托珠单抗治疗新型冠状病毒肺炎严重或危重型肺受累患者的疗效:一项回顾性研究
J Clin Med. 2022 Apr 20;11(9):2286. doi: 10.3390/jcm11092286.
6
Prognostic findings for ICU admission in patients with COVID-19 pneumonia: baseline and follow-up chest CT and the added value of artificial intelligence.COVID-19 肺炎患者 ICU 入院的预后发现:基线和随访胸部 CT 以及人工智能的附加值。
Emerg Radiol. 2022 Apr;29(2):243-262. doi: 10.1007/s10140-021-02008-y. Epub 2022 Jan 20.

本文引用的文献

1
CT Features and Short-term Prognosis of COVID-19 Pneumonia: A Single-Center Study from Kashan, Iran.新型冠状病毒肺炎的CT特征及短期预后:来自伊朗卡尚的一项单中心研究
Radiol Cardiothorac Imaging. 2020 Apr 20;2(2):e200130. doi: 10.1148/ryct.2020200130. eCollection 2020 Apr.
2
A systematic review of chest imaging findings in COVID-19.新型冠状病毒肺炎胸部影像学表现的系统评价
Quant Imaging Med Surg. 2020 May;10(5):1058-1079. doi: 10.21037/qims-20-564.
3
Radiological approach to COVID-19 pneumonia with an emphasis on chest CT.放射学方法在 COVID-19 肺炎中的应用,重点是胸部 CT。
Diagn Interv Radiol. 2020 Jul;26(4):323-332. doi: 10.5152/dir.2020.20260.
4
Well-aerated Lung on Admitting Chest CT to Predict Adverse Outcome in COVID-19 Pneumonia.胸部 CT 显示充气良好的肺可预测 COVID-19 肺炎的不良结局。
Radiology. 2020 Aug;296(2):E86-E96. doi: 10.1148/radiol.2020201433. Epub 2020 Apr 17.
5
COVID-19 pneumonia manifestations at the admission on chest ultrasound, radiographs, and CT: single-center study and comprehensive radiologic literature review.COVID-19肺炎入院时胸部超声、X光片及CT表现:单中心研究及放射学文献综述
Eur J Radiol Open. 2020;7:100231. doi: 10.1016/j.ejro.2020.100231. Epub 2020 Apr 4.
6
Clinics in diagnostic imaging (207). Coronavirus disease 2019 (COVID-19) atypical pneumonia.诊断影像学临床(207)。2019冠状病毒病(COVID-19)非典型肺炎。
Singapore Med J. 2020 Jul;61(7):363-369. doi: 10.11622/smedj.2020045. Epub 2020 Apr 3.
7
Diagnosis of the Coronavirus disease (COVID-19): rRT-PCR or CT?冠状病毒病(COVID-19)的诊断:实时 RT-PCR 还是 CT?
Eur J Radiol. 2020 May;126:108961. doi: 10.1016/j.ejrad.2020.108961. Epub 2020 Mar 25.
8
Covid-19 in Critically Ill Patients in the Seattle Region - Case Series.西雅图地区危重症新冠患者-病例系列。
N Engl J Med. 2020 May 21;382(21):2012-2022. doi: 10.1056/NEJMoa2004500. Epub 2020 Mar 30.
9
The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China.抗炎药物在治疗重症新型冠状病毒病 2019(COVID-19)患者中的应用:来自中国临床免疫学家的观点。
Clin Immunol. 2020 May;214:108393. doi: 10.1016/j.clim.2020.108393. Epub 2020 Mar 25.
10
Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.中国 COVID-19 患者 1590 例的合并症及其影响:一项全国性分析。
Eur Respir J. 2020 May 14;55(5). doi: 10.1183/13993003.00547-2020. Print 2020 May.

首次筛查时CT影像表现对新型冠状病毒肺炎患者住院或入住重症监护病房需求的预测价值

Predictive value of CT imaging findings in COVID-19 pneumonia at the time of first-screen regarding the need for hospitalization or intensive care unit.

作者信息

Tekcan Sanli Deniz Esin, Yildirim Duzgun, Sanli Ahmet Necati, Erozan Neval, Husmen Guray, Altundag Aytug, Tuzuner Filiz, Dikensoy Oner, Erel Kirisoglu Ceyda

机构信息

Department of Radiology, Acibadem Kozyatagi Hospital, Istanbul, Turkey.

Department of Radiology, Acibadem Taksim Hospital, Istanbul, Turkey.

出版信息

Diagn Interv Radiol. 2021 Sep;27(5):599-606. doi: 10.5152/dir.2020.20421.

DOI:10.5152/dir.2020.20421
PMID:33290242
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8480949/
Abstract

PURPOSE

In this study, we aimed to reveal the relationship between initial lung parenchymal involvement patterns and the subsequent need for hospitalization and/or intensive care unit admission in coronavirus disease 2019 (COVID-19) positive cases.

METHODS

Overall, 231 patients diagnosed with COVID-19 as proven by PCR were included in this study. Based on the duration of hospitalization, patients were divided into three groups as follows: Group 1, patients receiving outpatient treatment or requiring hospitalization <7 days; Group 2, requiring hospitalization ≥7 days; Group 3, patients requiring at least 1 day of intensive care at any time. Chest CT findings at first admission were evaluated for the following features: typical/atypical involvement of the disease, infiltration patterns (ground-glass opacities, crazy-paving pattern, consolidation), distribution and the largest diameters of the lesions, total lesion numbers, number of affected lung lobes, and affected total lung parenchyma percentages. The variability of all these findings according to the groups was analyzed statistically.

RESULTS

In this study, 172 patients were in Group 1, 39 patients in Group 2, and 20 patients in Group 3. The findings obtained in this study indicated that there was no statistically significant difference in ground-glass opacity rates among the groups (p = 0.344). The rates of crazy-paving and consolidation patterns were significantly higher in Groups 2 and 3 than in Group 1 (p = 0.001, p = 0.002, respectively). The rate of right upper, left upper lobe, and right middle lobe involvements as consolidation pattern was significantly higher in Group 3 than in Group 1 (p = 0.148, p = 0.935, p = 0.143, respectively). A statistically significant difference was also found between the affected lobe numbers, total lesion numbers, the diameter of the largest lesion, and the affected lung parenchyma percentages between the groups (p = 0.001). The average number of impacted lobes in Group 1 was 2; 4 in Group 2 and Group 3. The mean percentage of affected lung parenchyma percentage was 25% in Group 1 and Group 2, and 50% in Group 3.

CONCLUSION

In case of infiltration dominated by right middle or upper lobe involvement with a consolidation pattern, there is a higher risk of future intensive care need. Also, the need for intensive care increases as the number of affected lobes and percentage of affected parenchymal involvement increase.

摘要

目的

在本研究中,我们旨在揭示2019冠状病毒病(COVID-19)阳性病例的初始肺实质受累模式与随后住院和/或入住重症监护病房需求之间的关系。

方法

本研究共纳入231例经PCR确诊为COVID-19的患者。根据住院时间,患者分为以下三组:第1组,接受门诊治疗或住院时间<7天的患者;第2组,住院时间≥7天的患者;第3组,随时需要至少1天重症监护的患者。首次入院时的胸部CT表现评估以下特征:疾病的典型/非典型受累、浸润模式(磨玻璃影、铺路石样、实变)、病变的分布和最大直径、病变总数、受累肺叶数以及受累肺实质百分比。对所有这些发现根据分组进行统计学分析。

结果

本研究中,第1组有172例患者,第2组有39例患者,第3组有20例患者。本研究获得的结果表明,各组间磨玻璃影发生率无统计学显著差异(p = 0.344)。第2组和第3组的铺路石样和实变模式发生率显著高于第1组(分别为p = 0.001,p = 0.002)。第3组右上叶、左上叶和右中叶以实变模式受累的发生率显著高于第1组(分别为p = 0.148,p = 0.935,p = 0.143)。各组间受累肺叶数、病变总数、最大病变直径和受累肺实质百分比也存在统计学显著差异(p = 0.001)。第1组受累肺叶的平均数量为2个;第2组和第3组为4个。第1组和第2组受累肺实质百分比的平均值为25%,第3组为50%。

结论

如果以右中叶或上叶受累并伴有实变模式为主的浸润,未来需要重症监护的风险更高。此外,随着受累肺叶数量和受累实质百分比的增加,重症监护的需求也会增加。